Clinical Trials Browser

Phase 2 × Recurrent Uterine Corpus Sarcoma × Thalidomide × Clear all

NCT00025220 2019-07-23

Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Phase 2 Completed

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma